Abstract An Expert Working Group of the National Heart Foundation of Australia undertook a
review of systematic reviews of the evidence relating to major psychosocial risk factors to …

There is abundant evidence that the risk of atherosclerotic vascular disease is directly
related to plasma cholesterol levels. Accordingly, all of the national and transnational …

Background Long-term aspirin prevents vascular events but is only modestly effective.
Rivaroxaban alone or in combination with aspirin might be more effective than aspirin alone …

Background We evaluated whether rivaroxaban alone or in combination with aspirin would
be more effective than aspirin alone for secondary cardiovascular prevention. Methods In …

Background Aspirin is a well-established therapy for the secondary prevention of
cardiovascular events. However, its role in the primary prevention of cardiovascular disease …

Context The associations of low-density lipoprotein cholesterol (LDL-C), non–high-density
lipoprotein cholesterol (non–HDL-C), and apolipoprotein B (apoB) levels with the risk of …

Background In the primary analysis of the Aspirin in Reducing Events in the Elderly
(ASPREE) trial, now published in the Journal, we report that the daily use of aspirin did not …

Background—Diabetes mellitus increases the risk of cardiovascular disease (CVD) and all-
cause mortality. The relationship between milder elevations of blood glucose and mortality is …

Background Information on the use of aspirin to increase healthy independent life span in
older persons is limited. Whether 5 years of daily low-dose aspirin therapy would extend …

Background Elevated lipoprotein (a) is a genetic risk factor for cardiovascular disease in
general population studies. However, its contribution to risk for cardiovascular events in …